1163. Impact of Difficult-to-Treat Resistance on Survival in Gram-Negative Bacteremia: A Risk-Adjusted Analysis Using Electronic Health Record-based Clinical Data From 140 US Hospitals

Ítems similars

• External Validation of Difficult-to-Treat Resistance Prevalence and Mortality Risk in Gram-Negative Bloodstream Infection Using Electronic Health Record Data From 140 US Hospitals
  per: Kadri, Sameer S, et al.
  Publicat: (2019)
• Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents
  per: Kadri, Sameer S, et al.
  Publicat: (2018)
• Epidemiology of Inappropriate Empiric Antibiotic Therapy for Bacteremia Based on Discordant In vitro Susceptibilities: Risk factors and Taxon-level Variation in Burden and Outcome in 156 US hospitals, 2000–2014
  per: Kadri, Sameer S, et al.
  Publicat: (2017)
• 2398. Utilization Practices of Ceftazidime–Avibactam at Academic Medical Centers in the United States
  per: Strich, Jeffrey R, et al.
  Publicat: (2018)
• Inappropriate Empiric Antibiotic Therapy in Bloodstream Infections at U.S. Hospitals based on Discordant In vitro Susceptibilities: A Retrospective Cohort Analysis of Prevalence, Predictors and Mortality Risk
  per: Kadri, Sameer S., et al.
  Publicat: (2020)